aspartic acid has been researched along with Nausea in 9 studies
Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Monosodium glutamate induces behaviors thought to reflect headache and nausea in rats." | 8.12 | Peripheral N-methyl-D-aspartate receptor activation contributes to monosodium glutamate-induced headache but not nausea behaviours in rats. ( Benbow, T; Cairns, BE; Exposto, FG; Sheikhi, A; Svensson, P; Teja, F, 2022) |
| "Twenty-two patients with advanced malignant melanoma were entered in a pilot study receiving combination chemotherapy with PALA, vindesine, and cisplatin (PVP)." | 7.67 | PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study. ( Kleeberg, UR; Voigt, H, 1984) |
| "Monosodium glutamate induces behaviors thought to reflect headache and nausea in rats." | 4.12 | Peripheral N-methyl-D-aspartate receptor activation contributes to monosodium glutamate-induced headache but not nausea behaviours in rats. ( Benbow, T; Cairns, BE; Exposto, FG; Sheikhi, A; Svensson, P; Teja, F, 2022) |
| "Twenty-two patients with advanced malignant melanoma were entered in a pilot study receiving combination chemotherapy with PALA, vindesine, and cisplatin (PVP)." | 3.67 | PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study. ( Kleeberg, UR; Voigt, H, 1984) |
| "In 2594 patients with complete adverse event (AE) data, the incidence of grade 3 or greater 5FU-AEs in DPYD*2A, I560S, and D949V carriers were 22/25 (88." | 2.79 | DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147). ( Alberts, SR; Berenberg, JL; Diasio, RB; Goldberg, RM; Lee, AM; Pavey, E; Sargent, DJ; Shi, Q; Sinicrope, FA, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Benbow, T | 1 |
| Teja, F | 1 |
| Sheikhi, A | 1 |
| Exposto, FG | 1 |
| Svensson, P | 1 |
| Cairns, BE | 1 |
| Lee, AM | 1 |
| Shi, Q | 1 |
| Pavey, E | 1 |
| Alberts, SR | 1 |
| Sargent, DJ | 1 |
| Sinicrope, FA | 1 |
| Berenberg, JL | 1 |
| Goldberg, RM | 1 |
| Diasio, RB | 1 |
| Hayashi, R | 1 |
| Kitazawa, K | 1 |
| Sanada, D | 1 |
| Kato, N | 1 |
| Ohkoshi, T | 1 |
| Katsumata, Y | 1 |
| Yamaguchi, S | 1 |
| SMYTH, CJ | 1 |
| LEVEY, S | 1 |
| LASICHAK, AG | 1 |
| Tabrizi, SJ | 1 |
| Blamire, AM | 1 |
| Manners, DN | 1 |
| Rajagopalan, B | 1 |
| Styles, P | 1 |
| Schapira, AH | 1 |
| Warner, TT | 1 |
| YAKUSHIJI, M | 1 |
| YAMASHITA, E | 1 |
| ISAYAMA, Y | 1 |
| Voigt, H | 1 |
| Kleeberg, UR | 1 |
| O'Connell, MJ | 1 |
| Rubin, J | 1 |
| Schutt, AJ | 1 |
| Moertel, CG | 1 |
| Kvols, LK | 1 |
| Stegink, LD | 1 |
| Filer, LJ | 1 |
| Baker, GL | 1 |
4 trials available for aspartic acid and Nausea
| Article | Year |
|---|---|
DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2014 |
Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study.
Topics: Adenosine Triphosphate; Aspartic Acid; Brain; Choline; Creatine; Diarrhea; Dietary Supplements; Dose | 2003 |
Clinical trial of PALA and L-Alanosine in advanced colorectal carcinoma.
Topics: Adult; Aged; Alanine; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Clinical Trials | 1983 |
Effect of aspartame and sucrose loading in glutamate-susceptible subjects.
Topics: Aspartame; Aspartic Acid; Dipeptides; Double-Blind Method; Female; Glutamates; Headache; Humans; Mal | 1981 |
5 other studies available for aspartic acid and Nausea
| Article | Year |
|---|---|
Peripheral N-methyl-D-aspartate receptor activation contributes to monosodium glutamate-induced headache but not nausea behaviours in rats.
Topics: Amino Acids; Animals; Aspartic Acid; Female; Glutamic Acid; Headache; Kynurenic Acid; Male; Metoclop | 2022 |
Diffuse Leukoencephalopathy Associated with Dialysis Disequilibrium Syndrome.
Topics: Acidosis; Aspartic Acid; Coma; Female; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Ma | 2015 |
The relationship of glutamic and aspartic acids to the production of nausea and vomiting in man.
Topics: Acids; Amino Acids; Aspartic Acid; Glutamates; Glutamic Acid; Humans; Male; Nausea; Vomiting | 1947 |
[ON A TRIAL OF L-ASPARTIC ACID-K AND MG SALT IN THE FIELD OF GYNECOLOGY].
Topics: Aspartic Acid; Drug Therapy; Female; Gynecology; Humans; Hyperemesis Gravidarum; Nausea; Pregnancy; | 1964 |
PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study.
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Bone Marrow; C | 1984 |